Skip to content

Public FDA record

Z-1979-2019: The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the s

Recall record Z-1979-2019 for Roche Diagnostics Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1979-2019
Company in FDA record
Roche Diagnostics Corporation
FDA record creation date
Jul 16, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.

Source facts

Action
Urgent Medical Device Correction notification letters dated 6/3/19 were sent to customers.
Initiated
2019-06-03
Root cause
Material/Component Contamination
Terminated
2020-08-28
Distribution
The products were distributed to the following US states: AL, IN, and KY.
Recall number
Z-1979-2019
Recall status
Terminated
CDRH record ID
173499
FDA record created
2019-07-16
Recall event number
83095

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗